153 related articles for article (PubMed ID: 24201744)
21. Multimodality management of hepatocellular carcinoma larger than 10 cm.
Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
[TBL] [Abstract][Full Text] [Related]
22. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
[TBL] [Abstract][Full Text] [Related]
23. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
[TBL] [Abstract][Full Text] [Related]
24. Retrospective study on the effects of lipiodolization before a potentially curative hepatectomy for colorectal liver metastases: long-term results of a pilot study.
Utsunomiya T; Emi Y; Ikejiri K; Suzuki M; Saitsu H; Yakabe S; Nonaka M; Saku M; Yoshida K; Shimada M; Sugimachi K
Hepatogastroenterology; 2001; 48(39):790-3. PubMed ID: 11462925
[TBL] [Abstract][Full Text] [Related]
25. [Transarterial oil chemoembolization for hepatocellular carcinoma, in 100 cases].
Levy I; Verstandig A; Sasson T; Wolf D; Krichon I; Libson E; Levensart P; Papo O; Yurim O; Id A; Shouval D
Harefuah; 2000 Jan; 138(2):89-93, 174. PubMed ID: 10883065
[TBL] [Abstract][Full Text] [Related]
26. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
27. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact.
Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M;
Ann Surg; 2014 Feb; 259(2):336-45. PubMed ID: 23673768
[TBL] [Abstract][Full Text] [Related]
28. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
[TBL] [Abstract][Full Text] [Related]
29. Enhanced therapeutic efficacy of combined use of sorafenib and transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma.
Zhou L; Li J; Ai DL; Fu JL; Peng XM; Zhang LZ; Wang JY; Zhao Y; Yang B; Yu Q; Liu CZ; Wang HM
Jpn J Clin Oncol; 2014 Aug; 44(8):711-7. PubMed ID: 24855686
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors.
Uchino K; Tateishi R; Shiina S; Kanda M; Masuzaki R; Kondo Y; Goto T; Omata M; Yoshida H; Koike K
Cancer; 2011 Oct; 117(19):4475-83. PubMed ID: 21437884
[TBL] [Abstract][Full Text] [Related]
31. [Multidisciplinary Therapy for Hepatocellular Carcinoma with Peritoneal Dissemination].
Yamauchi N; Kido M; Komatsu S; Tanaka M; Kinoshita H; Tsugawa D; Awazu M; Ueno K; Toyama H; Terai S; Mukubou H; Ajiki T; Fukumoto T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1717-1719. PubMed ID: 29394753
[TBL] [Abstract][Full Text] [Related]
32. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
[TBL] [Abstract][Full Text] [Related]
33. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI
Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675
[TBL] [Abstract][Full Text] [Related]
34. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
Nishikawa H; Osaki Y; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Nishiguchi S
Oncol Rep; 2014 Jan; 31(1):65-72. PubMed ID: 24220763
[TBL] [Abstract][Full Text] [Related]
35. Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia.
Qin S; Bai Y; Lim HY; Thongprasert S; Chao Y; Fan J; Yang TS; Bhudhisawasdi V; Kang WK; Zhou Y; Lee JH; Sun Y
J Clin Oncol; 2013 Oct; 31(28):3501-8. PubMed ID: 23980077
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic value of hepatectomy and transcatheter arterial embolization (TAE) for hepatocellular carcinoma].
Takeda S; Tashiro H; Koho H; Abe Y; Nagafuchi Y; Okamoto K; Ohsato K
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1100-3. PubMed ID: 1335114
[TBL] [Abstract][Full Text] [Related]
37. Multimodality treatment with radiotherapy for huge hepatocellular carcinoma.
Han HJ; Kim MS; Cha J; Choi JS; Han KH; Seong J
Oncology; 2014; 87 Suppl 1():82-9. PubMed ID: 25427738
[TBL] [Abstract][Full Text] [Related]
38. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
39. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
Int J Oncol; 2013 Jan; 42(1):151-60. PubMed ID: 23174998
[TBL] [Abstract][Full Text] [Related]
40. Is intraoperative adjuvant therapy effective for satellite lesions in patients undergoing reduction surgery for advanced hepatocellular carcinoma?
Taniai N; Yoshida H; Mamada Y; Kawano Y; Mizuguchi Y; Akimaru K; Tajiri T
Hepatogastroenterology; 2006; 53(68):258-61. PubMed ID: 16608035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
